| Methods |
Randomised trial with concurrent eligible patients outside of the RCT. The non‐RCT patients were not in the trial because they refused participation. Cardiac transplant patients with hypogammaglobulinemia. No losses to follow up. |
| Data |
Characteristics of non‐RCT patiens presented and compared to RCT patients who received the same treatment. The 10 RCT control patients were mean 55 (6) years, eight men and two women.The 33 non‐randomised patients were mean 54 (10) years, 27 men and six women. |
| Comparisons |
Two RCT arms, the control arm patients were compared with similarly treated eligible non‐RCT patients. The experiemental treatment was 150 mg/kg CytoGam intravenously over 4 hours. The control patients were monitored. |
| Outcomes |
Clinical outcomes were assessed in all the patients, patients were followed for six months. Main outcome was cytomegalovirus infection. |
| Notes |
The two RCT treatments were not significantly different. |
